Actively Recruiting
Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-01-16
102
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate fertility preservation options for women of reproductive age who have undergone cancer or hematological treatments that may affect their fertility. It focuses on women in remission and seeks to understand how effective these preservation methods are, how they are used, and their psychological impacts. The study is conducted at the Amiens-Picardie University Hospital and is part of developing a fertility observatory to improve care quality and coordination for female cancer survivors. The study observes women aged 18 to 47 who have had a fertility preservation consultation before starting potentially harmful cancer treatments. It tracks various factors, including the type of fertility preservation used, the timing between diagnosis, preservation, and treatment, and the reproductive outcomes after remission. Researchers also assess how often preserved material is used and the success rate of such usage, along with psychological and family status correlations. Participants will be followed over time with evaluations focusing on reproductive outcomes within one year. The study collects detailed data on patient pathways, clinical decisions, and fertility outcomes to identify areas for better support and follow-up. The main measure is the occurrence of identifiable reproductive outcomes, complemented by secondary measures such as timing, treatment types, and patient choices concerning parenthood. The overall goal is to enhance understanding and improve fertility preservation care for women post-cancer treatment.
CONDITIONS
Brief Title
Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women
- Aged between 18 and 47 years
- Diagnosed with cancer or hematological disorders requiring potentially gonadotoxic treatment
- Having undergone a medical fertility preservation consultation
- Followed at Amiens Picardie University Hospital in the department of Reproductive Medicine
- Currently in remission
- Having expressed non-opposition to participation in the study
You will not qualify if you...
- Absence of remission
- Patients deprived of liberty by administrative or judicial decision, or placed under legal protection (guardianship or curators)
- Decline to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants are observed over time to evaluate fertility preservation outcomes and reproductive health following cancer remission or hematological pathology.
Visits scheduled according to clinical follow-up
Trial Site Locations
Total: 1 location
1
CHU Amiens Picardie
Amiens, France
Actively Recruiting
Research Team
C
CABRY-GOUBET Rosalie, Pr
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here